2023 - Research.com Medicine in Denmark Leader Award
2022 - Research.com Best Female Scientist Award
Anne Tybjærg-Hansen mainly focuses on Internal medicine, Endocrinology, Cholesterol, Odds ratio and Population study. Her Internal medicine study deals with Cardiology intersecting with Lipoprotein. Her Endocrinology research incorporates elements of Mutation and TM6SF2.
Her Cholesterol research is multidisciplinary, relying on both ANGPTL3 and Niacin. Anne Tybjærg-Hansen has included themes like Meta-analysis, Cancer, Case-control study and Oncology in her Odds ratio study. The study incorporates disciplines such as Cohort study and Pathology in addition to Population study.
Anne Tybjærg-Hansen spends much of her time researching Internal medicine, Endocrinology, Disease, Cholesterol and Odds ratio. Her studies in Internal medicine integrate themes in fields like Population study and Cardiology. Her work deals with themes such as Prospective cohort study, Mendelian randomization and Genotype, which intersect with Endocrinology.
Her Disease study incorporates themes from Epidemiology, Bioinformatics and Increased risk. Her Odds ratio research is multidisciplinary, incorporating perspectives in Gastroenterology, Surgery, Cohort study and Case-control study. The Lipoprotein research she does as part of her general Lipoprotein study is frequently linked to other disciplines of science, such as Context, therefore creating a link between diverse domains of science.
Her primary scientific interests are in Internal medicine, Population study, Endocrinology, Disease and Mendelian randomization. Many of her studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology. The concepts of her Population study study are interwoven with issues in Body mass index, Interquartile range and Allele.
Her research on Endocrinology frequently links to adjacent areas such as Lower risk. The Mendelian randomization study combines topics in areas such as Cohort study, Bioinformatics, Retinopathy, Mendelian Randomization Analysis and Risk factor. Her study in Hazard ratio is interdisciplinary in nature, drawing from both Proportional hazards model and Cardiology.
Her main research concerns Internal medicine, Endocrinology, Odds ratio, Genome-wide association study and Cholesterol. Her Internal medicine research incorporates themes from Diabetes mellitus and Population study. Her study in Population study is interdisciplinary in nature, drawing from both Dementia and Hazard ratio.
Her Odds ratio study incorporates themes from Mendelian randomization and Mendelian Randomization Analysis. Her research in Genome-wide association study focuses on subjects like Genetic association, which are connected to Computational biology and Quantitative trait locus. Her Cholesterol research is multidisciplinary, relying on both Lower risk, Confidence interval, Prospective cohort study and Environmental health.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Børge G. Nordestgaard;Marianne Benn;Peter Schnohr;Anne Tybjærg-Hansen.
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society
Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg.
European Heart Journal (2013)
Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study
Benjamin F. Voight;Benjamin F. Voight;Benjamin F. Voight;Gina M. Peloso;Gina M. Peloso;Marju Orho-Melander;Ruth Frikke-Schmidt.
web science (2012)
Lipoprotein(a) as a cardiovascular risk factor: current status
Børge G. Nordestgaard;M. John Chapman;Kausik Ray;Jan Borén.
European Heart Journal (2010)
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M John Chapman;Henry N Ginsberg;Pierre Amarenco;Felicita Andreotti.
European Heart Journal (2011)
Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
Pia R. Kamstrup;Anne Tybjærg-Hansen;Rolf Steffensen;Børge G. Nordestgaard.
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jørgensen;Ruth Frikke-Schmidt;Børge G Nordestgaard;Anne Tybjærg-Hansen.
The New England Journal of Medicine (2014)
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Anette Varbo;Marianne Benn;Anne Tybjærg-Hansen;Anders B. Jørgensen.
Journal of the American College of Cardiology (2013)
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.
Julia Kozlitina;Eriks Smagris;Stefan Stender;Børge G Nordestgaard.
Nature Genetics (2014)
Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
Jeppe Zacho;Anne Tybjærg-Hansen;Jan Skov Jensen;Peer Grande.
The New England Journal of Medicine (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: